CELL SEARCH SYSTEM产品代理
CELL SEARCH SYSTEM产品代理
Menarini Silicon Biosystems 的使命和热情是通过创造技术和产品来推动医疗保健和个性化医疗的发展，这些技术和产品有助于在每个单细胞水平上揭示健康和疾病的生物学复杂性。
我们的首要任务是通过检测和分析与疾病相关的重要但罕见的细胞来改进人类健康的诊断和治疗方法，并为研究人员和肿瘤学家提供无与伦比的分子表征精度。
我们的 CELLSEARCH® 技术通过简单的微创液体活检提供临床验证的测试，该活检可捕获、分离和计数循环肿瘤细胞 (CTC)，以获得有价值的肿瘤学信息，从而做出明智的临床决策。 CELLSEARCH® CTC 产品线提供体外诊断 (IVD) 应用，这些应用已获得 FDA 批准，用于预测转移性乳腺癌 (mBC)、前列腺 (mPC) 和结直肠 (mCRC) 癌的总体和无进展生存期，是金标准在 CTC 技术中。
Menarini Silicon Biosystems 还提供端到端的仅用于研究的 (RUO) 产品和工作流程解决方案，这些产品和工作流程解决方案采用 CELLSEARCH® 和 DEPArray™ 技术，用于在临床研究环境中通过简单的血液测试对 CTC 进行计数、分离和分子表征。
Biosystems. Menarini Silicon Biosystems is a wholly owned and operated subsidiary of the Menarini Group, a multinational pharmaceutical, biotechnology and diagnostics company headquartered in Florence, Italy. Menarini Silicon Biosystems is based in Bologna, Italy, with U.S. headquarters in Huntingdon Valley, Pennsylvania.
The mission and passion of Menarini Silicon Biosystems is to advance healthcare and personalized medicine by creating technologies and products that help uncover the biological complexities of health and disease at the level of each single cell.
Our highest priority is to improve diagnostic and therapeutic approaches to human health by enabling detection and analysis of important, but rare, cells associated with disease, and to provide researchers and oncologists with access to unparalleled precision in molecular characterization.
Our CELLSEARCH® technology provides a clinically validated test from a simple, minimally invasive liquid biopsy that captures, isolates and enumerates circulating tumor cells (CTCs) for valuable oncologic information to make informed clinical decisions. The CELLSEARCH® CTC product line provides in vitro diagnostic (IVD) applications that are FDA-cleared for predicting overall and progression-free survival in metastatic breast (mBC), prostate (mPC), and colorectal (mCRC) cancers
nd is the gold standard in CTC technologies.
Menarini Silicon Biosystems also provides end-to-end Research Use Only (RUO) products and workflow solutions with CELLSEARCH® and DEPArray™ technologies for the enumeration, isolation, and molecular characterization of CTCs from a simple blood test in the clinical research setting.
